Keyphrases
Staphylococcus Aureus
84%
Clostridioides Difficile
59%
Matrix-assisted Laser Desorption Ionization-time of Flight Mass Spectrometry (MALDI-TOF MS)
49%
Difficile
45%
Methicillin-resistant Staphylococcus Aureus
42%
Clostridium Difficile Infection
38%
Clinically Significant
32%
Pseudomonas Aeruginosa (P. aeruginosa)
32%
VITEK MS
29%
Blood Culture
29%
Enterobacteriaceae
29%
Methicillin-resistant S. Aureus
28%
Susceptibility Testing
27%
Antimicrobial Resistance
26%
Bloodstream Infection
25%
Multicentre Evaluation
25%
Multidrug-resistant Organisms
24%
Escherichia Coli
24%
Epidemiology
24%
Antimicrobial Susceptibility
22%
Urinary Tract Infection
22%
COVID-19
21%
Intensive Care Unit
21%
Multidrug-resistant Pseudomonas Aeruginosa (MDRPA)
21%
Pakistan
20%
Soft Tissue Infection
20%
Disc Diffusion
20%
Skin Tissue
20%
Diagnostic Test
20%
Strain Typing
20%
Hospitalized Patients
19%
Carbapenem Resistance
19%
Methicillin Resistance
18%
Health Personnel
18%
Molecular Epidemiology
17%
Antimicrobial
17%
Group B Streptococcus
17%
Carbapenemase
17%
Urine Specimen
17%
Bruker Biotyper
17%
Vancomycin
16%
Academic Medical Centers
16%
Non-susceptible
16%
Turnaround Time
16%
Comparative Genomics
16%
Antibiotics
16%
Carbapenemase Production
16%
Staphylococcus Pseudintermedius
16%
Decolonization
16%
Antibiotic Resistance
16%
Immunology and Microbiology
Staphylococcus Aureus
100%
Infectious Agent
86%
Matrix-Assisted Laser Desorption-Ionization
59%
Antimicrobial Resistance
55%
Time-of-Flight Mass Spectrometry
50%
Pseudomonas aeruginosa
42%
Methicillin-Resistant Staphylococcus Aureus
42%
Peptoclostridium difficile
37%
Enterobacteriaceae
34%
Antibiotic Sensitivity
34%
Escherichia coli
33%
Microorganism
32%
Microbiome
27%
Minimum Inhibitory Concentration
26%
Disk Diffusion
26%
Gram-Negative Bacteria
26%
Urinary Tract
25%
Prevalence
23%
Lineages
22%
Clinical Microbiology
22%
Type Strain
22%
Cladistics
21%
Microflora
20%
Gut Microbiome
20%
Enterobacterales
18%
Turnaround Time
17%
Klebsiella pneumoniae
17%
Agar
17%
Streptococcus Agalactiae
15%
Dynamics
14%
Broth Dilution
14%
Anaerobic Bacterium
13%
Plasmid
13%
Corynebacterium striatum
12%
Bacteroides fragilis
12%
Soft Tissue
12%
Etest
12%
Staphylococcus Intermedius
12%
Interleukin 7
12%
Intestine Flora
12%
Whole Genome Sequencing
12%
Gene Sequence
12%
Microbiology
11%
Haemophilus influenzae
11%
Resistome
11%
Molecular Epidemiology
10%
Phylogeny
10%
Staphylococcus Pseudintermedius
10%
RNA Gene
10%
Corpus Striatum
9%
Medicine and Dentistry
Infection
58%
Diagnosis
43%
Pathogen
38%
Peptoclostridium difficile
31%
Clostridium Difficile Infection
29%
Disease
28%
Matrix Assisted Laser Desorption Ionization Time of Flight Mass Spectrometry
26%
Bloodstream Infection
26%
Carbapenem
22%
Cohort Effect
19%
Prevalence
17%
Staphylococcus Aureus
17%
Antibiotic Resistance
17%
Severe Acute Respiratory Syndrome Coronavirus 2
16%
Antiinfective Agent
15%
Tertiary Care
15%
Pediatrics
14%
Antibiogram
14%
Gut
14%
Enzyme Immunoassay
13%
Clinical Trial
12%
Diarrhea
12%
Molecular Epidemiology
12%
Clinician
12%
Sepsis
10%
Carbapenemase
10%
Propionibacterium acnes
9%
Urinary Tract Infection
9%
Blood Culture
9%
Gram-Positive Bacteria
9%
Mycobacteria
9%
Azithromycin
9%
Pseudomonic Acid
9%
Soft Tissue Infection
9%
Nucleic Acid Amplification
9%
Beta-Lactamase
8%
Carbapenem-Resistant Enterobacteriaceae
8%
Human Respiratory Syncytial Virus
8%
Intensive Care Unit
8%
Microbiome
7%
RNA 16S
7%
Antimicrobial Therapy
7%
Bronchiolitis
7%
Pseudomonas aeruginosa
7%
Fungemia
7%
Patient Care
7%
Recurrent Disease
7%
Chlorhexidine
7%
Public Health
7%
Drug Therapy
6%